IC-487892

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameIC-487892
Drug Alias Namechemokine antagonists (ICOS/Array)CCR4 receptor antagonists (ICOS/Array)macrophage derived chemokine (ICOS)chemokine antagonists (Eli Lilly/Array)IC-487952 +[7] 
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionChemokine receptors antagonists
TargetsChemokine receptors
Therapy Area/IndicationsInflammationHypersensitivityCommunicable Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIcos Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And CompanyArray Biopharma IncIcos Corp
Active IndicationsN/A
Inactive IndicationsInflammationHypersensitivityCommunicable Diseases

Other Information

ATC CodeN/A
Related LinksN/A